531521 Stock Overview
Engages in the manufacture and sale of ayurvedic and herbal products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Desh Rakshak Aushdhalaya Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹15.04 |
| 52 Week High | ₹15.04 |
| 52 Week Low | ₹6.95 |
| Beta | -0.0049 |
| 11 Month Change | 10.18% |
| 3 Month Change | n/a |
| 1 Year Change | 127.19% |
| 33 Year Change | n/a |
| 5 Year Change | 250.58% |
| Change since IPO | 50.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531521 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 10.2% | 0.5% | 0.5% |
| 1Y | 127.2% | 42.5% | 27.5% |
Return vs Industry: 531521 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 531521 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 531521 volatility | |
|---|---|
| 531521 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531521's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine 531521's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1901 | 21 | Tosh Jain | www.deshrakshak.in |
Desh Rakshak Aushdhalaya Limited engages in the manufacture and sale of ayurvedic and herbal products in India. It manufactures and processes ayurvedic medicines, ayurvedic composite drug kits, dye kits, and CHW kits. The company also provides medicines in tablet, capsule, pills, powder, syrup, and liquid forms.
Desh Rakshak Aushdhalaya Limited Fundamentals Summary
| 531521 fundamental statistics | |
|---|---|
| Market cap | ₹66.75m |
| Earnings (TTM) | ₹5.34m |
| Revenue (TTM) | ₹63.36m |
12.5x
P/E Ratio1.1x
P/S RatioIs 531521 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531521 income statement (TTM) | |
|---|---|
| Revenue | ₹63.36m |
| Cost of Revenue | ₹26.92m |
| Gross Profit | ₹36.44m |
| Other Expenses | ₹31.10m |
| Earnings | ₹5.34m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 57.51% |
| Net Profit Margin | 8.43% |
| Debt/Equity Ratio | 35.4% |
How did 531521 perform over the long term?
See historical performance and comparison